Evaluation of the prognostic factors in school age children who experienced neonatal seizures

This prospective study aimed to evaluate long-term neurodevelopmental outcomes and risk factors of the previously reported cohort, at their school age. We included neonates whose seizures were directly observed by the child neurologist or neonatologist based on clinical observations. They were asses...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsy & behavior 2020-01, Vol.102, p.106673-106673, Article 106673
Main Authors: Pembegul Yıldız, Edibe, Tatlı, Burak, Ulak Ozkan, Melis, Erarslan, Emine, Aydınlı, Nur, Çalışkan, Mine, Özmen, Meral
Format: Article
Language:English
Subjects:
Cerebral palsy
Epilepsy
Neonatal seizure
Newborn
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This prospective study aimed to evaluate long-term neurodevelopmental outcomes and risk factors of the previously reported cohort, at their school age. We included neonates whose seizures were directly observed by the child neurologist or neonatologist based on clinical observations. They were assessed for cognitive and neurological outcomes at the age of 9–11 years. The test battery included a neurological examination, the Wechsler Intelligence Scale for Children—Revised (WISC-R) test, and patients with the diagnosis of cerebral palsy (CP) were graded according to the Gross Motor Function Classification System (GMFCS). The primary outcome of this study was to determine risk factors for the long-term prognosis of neonatal seizures. For the long-term follow-up, 97 out of 112 patients of the initial cohort were available (86.6%). We found that 40 patients (41%) have the normal prognosis, 22 patients (22.7%) have the diagnosis of CP, and 30 patients (30.9%) were diagnosed as having epilepsy. Twelve out of 22 patients with CP had the diagnosis of epilepsy. The WISC-R full-scale IQ scores were 85 points in 40 patients (41.2%). According to GMFCS, 10 patients were classified as levels 1–2, and 12 patients were classified as levels 3–5. In multivariate regression analyses, 5-min APGAR score
ISSN:1525-5050
1525-5069
DOI:10.1016/j.yebeh.2019.106673